Artificial intelligence is beginning to reshape how cancer treatment decisions are made. In a significant development, the ...
Learn how AI medical discovery is bridging the gap between lab research and bedside treatments, resulting in faster and more ...
Charles River is rolling out an artificial intelligence-backed digital pathology platform with a goal of trimming at least ...
A doctor finishes a consultation and turns back to their screen. An AI tool summarises the latest literature, compares ...
Digital pathology and artificial intelligence are transforming the drug development landscape, accelerating the path to ...
Discusses Bezisterim's Mechanism of Action and Its Potential in Addressing Parkinson's Disease Pathology May 7, 2026 2:00 PM ...
Daiichi Sankyo has entered into a collaboration with Paris-based Waiv intended at digital pathology biomarker discovery for an ADC programme.
Roche has signed a definitive merger agreement for the acquisition of US-based PathAI in a deal valued at up to $1.05bn.
FDA Pre-New Drug Application (NDA) meeting granted for QTORIN™ rapamycin for the treatment of microcystic lymphatic ...
Hamamatsu Photonics is pleased to announce an expansion of the intended use of the NanoZoomer MD series in Europe to include ...
Discusses Approval of AUVELITY for Agitation Associated With Dementia Due to Alzheimer's Disease May 1, 2026 8:00 ...
DeciBio Consulting LLC’s latest market report, "Digital & Computational Pathology Market Report 2026-2031," states that the global digital pathology market, driven by an influx of open platforms that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results